MIR4771-1

Across TCGA pan-cancer cohorts, MIR4771-1 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated MIR4771-1 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MIR4771-1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR4771-1 expression acts as an unfavorable survival marker.

KIRC, PAAD, and LUAD are the cancer types where MIR4771-1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	All	0.099	0.869	<.001	90	view →
PAAD	OS	Tertile	All	0.094	0.640	<.001	72	view →
LUAD	OS	Tertile	All	0.161	0.812	<.001	72	view →
LAML	DFS	Tertile	All	0.407	0.588	.048	18	view →
BRCA	DFS	Tertile	All	0.783	0.950	.019	12	view →
SARC	OS	Tertile	All	0.463	0.864	.021	6	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

MIR4771-1–KIRC (DFS)

Open the KIRC breakdown →